News
Ignite Biomedical and Liquid Biosciences Partner to Discover First-in-Class Drug Targets
8+ hour, 25+ min ago (218+ words) Turn your PR data into actionable intelligence with comprehensive reporting and analytics on every campaign. Provide a secure and confidential reporting channel to protect your organization and employees. Tuesday, 09 June 2026 08: 00 AM No approved drug, clinical-stage asset, or competing research program…...
Sorting cells" inner structures provides new path to drug development
17+ hour, 17+ min ago (486+ words) image: A microscope image of a cell infected with respiratory syncytial virus that has been treated with an antiviral drug. The drug causes shape changes to the viral condensates (shown in yellow), resulting in a disruption of viral replication. The…...
Lab-grown canine muscle cells offer solution for early therapeutic testing
19+ hour, 5+ min ago (774+ words) Myok9 cell line helps researchers evaluate new treatments in the lab " reducing animal use and accelerating progress in muscle disease and therapy development. image: Dr. Peter Nghiem holds a vial containing Myok9 canine muscle cells in a laboratory. view more Credit: Texas…...
Engineered phages use molecular anchors to enter human cells
16+ hour ago (275+ words) This shows that epithelial binding is not merely a curious side effect but instead an evolutionarily advantageous strategy driven by modular'phage surface proteins. The study also raises new questions, including if and how long internalized phages remain intact inside cells,…...
GELITA Unveils Next-Generation Excipient Innovations at BIO International 2026 in San Diego
19+ hour, 59+ min ago (228+ words) EBERBACH, Germany and SIOUX CITY, Iowa, June 12, 2026 /PRNewswire/ -- GELITA, a global leader in collagen protein solutions, will showcase its latest excipient technology at BIO International 2026 in San Diego. Known for its expertise in gelatin and collagen peptides, GELITA continues to…...
Abridge partners with Eli Lilly, Nvidia as AI scribe eyes expansion
22+ hour, 10+ min ago (359+ words) The company is working with Nvidia to build a foundation model for clinical conversations, and it scored a strategic investment from drugmaker Eli Lilly, Abridge announced during a sweeping keynote. Founded in 2018, Abridge develops an AI scribe for providers. The…...
How the Line Between Clinical Data and Real-World Evidence Is Blurring
4+ day, 13+ hour ago (498+ words) Applied Clinical Trials Online How the Line Between Clinical Data and Real-World Evidence Is Blurring In this video interview, Raj Indupuri, CEO and co-founder of e Clinical Solutions, explains why organizations that build infrastructure capable of harmonizing clinical and real-world…...
Nvidia teams up with Abridge to build AI model for healthcare: report | artificial intelligence | Crypto Rank. io
1+ day, 18+ hour ago (613+ words) Nvidia is expanding its presence in healthcare artificial intelligence through a new partnership with medical technology startup Abridge, as competition intensifies among technology companies seeking to apply AI tools across the healthcare industry. According to a report by The Wall…...
Insilico Medicine Connects Technology and Clinical Innovation at Morgan
23+ hour, 57+ min ago (893+ words) In a landmark event scheduled for June 18, 2026, in Shanghai, Dr. Alex Zhavoronkov, the visionary founder and CEO of Insilico Medicine, will present groundbreaking insights at the Morgan Stanley China Biopharma Symposium. His keynote, nestled within the forum entitled "AI-Driven Drug…...
Parexel to showcase AI, real-world evidence and patient-centric innovations at DIA 2026
1+ day, 5+ hour ago (213+ words) Parexel, a leading global clinical development partner, will play a prominent role at the 2026 Drug Information Association (DIA) Global Annual Meeting. The conference, scheduled from June 14-18 in Philadelphia, brings together life sciences professionals from across the globe to discuss emerging…...